Tenaya Therapeutics, Inc. (TNYA)
0.8404
+0.05
(+6.35%)
USD |
NASDAQ |
May 07, 16:00
0.8255
-0.01
(-1.77%)
After-Hours: 18:28
Tenaya Therapeutics Free Cash Flow : -68.88M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Marker Therapeutics, Inc. | -12.01M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Vericel Corp. | 24.75M |
| Anavex Life Sciences Corp. | -34.08M |
| Protagonist Therapeutics, Inc. | -117.90M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.94M |
| Cash from Investing (Quarterly) | -0.067M |
| Cash from Financing (Quarterly) | 58.24M |
| Free Cash Flow Per Share (Quarterly) | -0.08 |
| Free Cash Flow to Equity (Quarterly) | -13.31M |
| Free Cash Flow to Firm (Quarterly) | -14.01M |
| Free Cash Flow Yield | -53.65% |